Health Care & Life Sciences » Pharmaceuticals | Concordia International Corp.

Concordia International Corp. | Cash Flow

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
2,504.90
12,800.60
37,645.60
1,741,070.60
2,064,790.10
Depreciation, Depletion & Amortization
142.20
12,336.80
97,599.70
244,789.90
296,448.60
Other Funds
1,343.60
-
11,770.30
189,689.10
27,003.80
Funds from Operations
20,120.40
43,373.10
187,635.80
199,176.80
68,475.20
Changes in Working Capital
31,257.90
37,470.90
86,402.70
9,527.50
55,087.50
Net Operating Cash Flow
51,378.30
5,902.20
101,233.20
208,704.30
13,387.70
Capital Expenditures
110.30
719.00
2,620.20
2,492.20
3,204.80
Sale of Fixed Assets & Businesses
-
4.40
12,793.80
-
1,438.20
Net Investing Cash Flow
61,170.10
325,518.30
4,860,615.10
43,136.80
1,766.60
Cash Dividends Paid - Total
-
6,731.70
12,870.50
15,206.10
-
Issuance/Reduction of Debt, Net
15,087.00
260,606.20
3,929,429.00
412,755.60
74,348.70
Net Financing Cash Flow
53,994.40
319,425.00
4,915,602.60
207,971.70
101,352.50
Net Change in Cash
44,202.60
142.50
144,157.50
321,252.50
92,012.00
Free Cash Flow
51,268.00
5,183.20
98,613.00
206,212.20
16,592.50
Net Assets from Acquisitions
61,059.80
-
-
-
-
Change in Capital Stock
40,251.10
65,550.50
1,010,814.40
111.30
-
Exchange Rate Effect
-
48.60
12,063.20
52,286.70
24,494.70
Other Uses
-
324,803.70
4,870,788.70
40,644.60
-

About Concordia International

View Profile
Address
277 Lakeshore Road East
Oakville Ontario L6H 1J9
Canada
Employees -
Website http://www.concordiarx.com
Updated 09/14/2018
Concordia International Corp. is a pharmaceutical company, which engages in owning and licensing a diversified portfolio of branded and generic prescription products. It operates through the Concordia North America and Concordia International segments. The Concordia North America segment focuses primarily on the United States pharmaceutical market and offers products under the brand of Donnatal, Zonegran, Nilandron, Lanoxin, Plaquenil, and Photofrin.